Culture and Well-being: Art as Prescription Therapy ("Art on Prescription")
Launched by KAVADIA ELENI · Apr 9, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The "Art on Prescription" clinical trial is exploring how engaging with various art activities can help improve mental health for people dealing with conditions like anxiety, depression, schizophrenia, and autism. Participants in the study will be divided into two groups: one group will take part in art activities, while the other will be on a waitlist and not participate in the art intervention. This trial is currently recruiting participants aged 10 to 99 who can communicate their thoughts and complete questionnaires about their experiences.
To be eligible for the trial, participants need to be able to engage in activities on their own and commit to the study requirements. It’s important that they are not currently experiencing substance dependency or inconsistently following prescribed medications. Those who join can expect to share their thoughts and feelings through art, which may help enhance their overall well-being. This trial aims to understand the potential benefits of art in managing mental health conditions, making it an exciting opportunity for those looking for new ways to support their emotional health.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • age range: 10-99 years
- • be able to communicate effectively in order to provide answers to questionnaires that he/she will be asked to complete
- • be able to commit to monitoring the action
- • be able to participate in the activity alone (unaccompanied, without a carer),
- • be able to answer the questionnaires
- • to have legal capacity
- Exclusion Criteria:
- • active dependency,
- • patients that are not consistent in following pharmaceutical drugs,
- • patients from different Patient Association which is not "affiliated" with a Mental Health Professional Therapist.
About Kavadia Eleni
Kavadia Eleni is a dedicated clinical trial sponsor committed to advancing medical research and enhancing patient care through innovative therapeutic solutions. With a focus on rigorous scientific methodology and ethical standards, Kavadia Eleni collaborates with healthcare professionals and research institutions to design and implement clinical trials that address unmet medical needs. The organization prioritizes patient safety and data integrity, leveraging cutting-edge technologies and insights to drive the development of effective treatments across various therapeutic areas. Through its comprehensive approach, Kavadia Eleni aims to contribute significantly to the advancement of healthcare and improve outcomes for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Athens, , Greece
Patients applied
Trial Officials
Nikos Stefanis, PhD
Principal Investigator
University Mental Health Research Institute, Athens, Greece
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported